Valuation: Beijing Tiantan Biological Products Co., Ltd.

Capitalization 39.01B 5.43B 4.65B 4.33B 4.04B 7.44B 466B 8.3B 52.55B 19.79B 219B 20.38B 19.96B 801B P/E ratio 2025 *
23x
P/E ratio 2026 * 20.1x
Enterprise value 34.8B 4.85B 4.15B 3.86B 3.6B 6.64B 416B 7.41B 46.88B 17.65B 195B 18.18B 17.8B 714B EV / Sales 2025 *
5.13x
EV / Sales 2026 * 4.38x
Free-Float
46.44%
Yield 2025 *
0.44%
Yield 2026 * 0.59%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.87%
1 week+0.10%
Current month+2.71%
1 month+2.02%
3 months-6.28%
6 months+2.92%
Current year-3.85%
More quotes
1 week 19.46
Extreme 19.46
19.96
1 month 18.88
Extreme 18.88
20.21
Current year 18.88
Extreme 18.88
23.61
1 year 18.88
Extreme 18.88
27.6
3 years 16.11
Extreme 16.1083
27.6
5 years 12.44
Extreme 12.4444
37.15
10 years 6.53
Extreme 6.5347
37.15
More quotes
Manager TitleAgeSince
Investor Relations Contact - 2006-02-28
Corporate Secretary 46 2002-12-31
Director of Finance/CFO 55 2017-04-25
Director TitleAgeSince
Chairman 58 2022-12-04
Director/Board Member 51 2017-05-24
Chairman 63 2016-10-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.87%+0.10%-20.01%+12.36% 5.43B
+0.38%+2.47%-19.36%-16.27% 78.4B
-0.01%-0.84%-49.96%-9.81% 57.9B
+0.19%+3.30%+25.36%+26.44% 53.09B
+2.15%+0.41%+22.47%+104.51% 37.64B
+0.75%-3.43%-42.91%-40.80% 18.82B
+3.36%+11.03%+116.52%+146.47% 18.77B
+3.62%+14.76%+78.02%+797.23% 18.75B
-0.04%-.--%+67.84%+138.68% 14.02B
+1.44%+0.74%+8.17%-13.49% 13.4B
Average +1.10%+0.74%+18.62%+114.53% 31.62B
Weighted average by Cap. +0.94%+0.22%+4.99%+70.38%
See all sector performances

Financials

2025 *2026 *
Net sales 6.78B 944M 809M 753M 702M 1.29B 81.03B 1.44B 9.13B 3.44B 38.01B 3.54B 3.47B 139B 7.65B 1.07B 912M 849M 792M 1.46B 91.41B 1.63B 10.3B 3.88B 42.87B 4B 3.91B 157B
Net income 1.72B 240M 205M 191M 178M 328M 20.58B 366M 2.32B 874M 9.65B 899M 881M 35.34B 1.96B 273M 234M 217M 203M 373M 23.4B 417M 2.64B 993M 10.97B 1.02B 1B 40.18B
Net Debt -4.21B -587M -502M -468M -436M -803M -50.34B -897M -5.67B -2.14B -23.61B -2.2B -2.15B -86.46B -5.47B -762M -653M -608M -566M -1.04B -65.41B -1.16B -7.37B -2.78B -30.68B -2.86B -2.8B -112B
More financial data * Estimated data
Logo Beijing Tiantan Biological Products Co., Ltd.
BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED is a China-based company principally engaged in the biopharmaceutical businesses. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and intravenous immunoglobulin (IVIG), among others. The Company mainly distributes its products within domestic markets and to Hong Kong markets.
Employees
5,298
More about the company
Date Price Change Volume
25-07-16 19.71 ¥ +0.87% 10,567,480
25-07-15 19.54 ¥ -1.41% 12,634,220
25-07-14 19.82 ¥ +0.81% 16,487,880
25-07-11 19.66 ¥ -0.20% 12,941,180
25-07-10 19.70 ¥ +0.05% 10,340,320

End-of-day quote Shanghai S.E., July 15, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
CCC
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.71CNY
Average target price
28.00CNY
Spread / Average Target
+42.06%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600161 Stock